A potash-focused tariff on Russia and Belarus wouldn't lift all fertilizer stocks equally — Nutrien's Saskatchewan-heavy, CUSMA-compliant potash mix captures the price umbrella far more directly than Mosaic's Florida-phosphate-dependent footprint.
The lede: Potash has no substitute in row-crop agriculture, and Russia and Belarus together control roughly a third of global supply — a chokepoint Washington has weaponized before and could again. Belaruskali and Russia's Uralkali sit alongside Nutrien and Mosaic as the world's four dominant potash suppliers. If the U.S. reverses course and slaps new tariffs or duties on Russian- and Belarusian-origin potash (mirroring the escalating EU duty schedule, which ramps toward roughly €430/tonne by 2028), the effect isn't a uniform "fertilizer stocks up" trade. It's a reallocation of pricing power toward whichever North American producer has the most exposed potash tonnage and the least offsetting business elsewhere — and that split is exactly where Nutrien and Mosaic diverge.
Who cashes in:
Potash has no substitute in row-crop agriculture — which is exactly why a chokepoint tariff doesn't lift all fertilizer stocks equally.
- Nutrien (NTR) is the single biggest beneficiary of any measure that constrains Belarusian/Russian potash. It is the world's largest potash producer, mining almost entirely in Saskatchewan — CUSMA/USMCA-compliant tonnage that crosses the border tariff-free and captures the full benefit of a price umbrella lifted by squeezed Black Sea-adjacent supply. Its Retail segment (crop nutrients, seed, crop protection sold direct to farmers) also lets it recapture margin on the input-cost side even if farmers grumble about pricier potash.
- Mosaic (MOS) also gains, but more narrowly. It runs its own Canadian potash operations (Esterhazy — the largest potash mine on earth — plus Belle Plaine and Colonsay), so tighter Belarusian/Russian supply lifts realized potash prices there too. But potash is the smaller half of Mosaic's business.
- Corteva (CTVA) benefits indirectly: seed and crop-protection demand is sticky, and higher fertilizer costs for growers rarely dent Corteva's own pricing power, while a tighter ag-input complex generally signals firm farm economics.
Who is exposed:
- Mosaic (MOS) is the name most exposed to the asymmetry of this trade action. Its center of gravity is phosphate, not potash — Florida (and Louisiana) phosphate rock feeds its DAP/MAP production, a business with its own cost pressures (energy, sulfur, environmental liability) that a potash-focused tariff does nothing to help. Mosaic gets a smaller potash windfall than Nutrien relative to its total earnings base, so the stock's "tariff beneficiary" bounce tends to be shallower and faster to fade.
- Tyson (TSN) and other protein/livestock names absorb higher feed-grain costs indirectly as corn and soy input costs rise with pricier potash — a slow-moving margin drag, not a headline shock.
- Deere (DE) faces a secondary risk: if fertilizer-driven input inflation squeezes farm cash margins, equipment capex is often the first thing growers defer.
The play / what to watch: Washington has moved the other way as recently as December 2025, when Treasury's OFAC issued a general license authorizing transactions with Belaruskali — easing, not tightening, potash sanctions, which knocked MOS and NTR down together. That reversal is the tell: potash policy here swings on sanctions diplomacy as much as trade protectionism, and it can flip in either direction with little notice. Watch Federal Register proclamations and OFAC's Belarus sanctions program for the next move, and track Nutrien's realized potash price versus Mosaic's phosphate margins in quarterly filings — that spread is the real scoreboard.
Source: original report ↗
Free alerts Free: catalyst alerts, straight to your inbox.
Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Money Racket Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $40/mo Join the owners who run ahead of the industry. Cancel anytime, one click.